Bringing technologies into application: The LPI contributes to W3+ Fair Jena
How can photonic technologies be rapidly and successfully brought into clinical application? The LPI addressed this question in its program […]
© Telluride Architektur
The Leibniz Center for Photonics in Infection Research (LPI) is a user-open one-stop agency.
Its unique infrastructure will accelerate and support the development of light-based diagnostic methods and novel therapeutic approaches for the treatment of infectious diseases. All development steps from concept to medical device are included in a holistic process. Professional quality management, early consideration of regulatory requirements and clinical evidence ensure sustained application.
Until full establishment of the LPI infrastructure in 2030, projects can be managed decentrally. In 2027, the First-in-Patient Unit will already be available for pilot studies at point-of-care.
LPI focuses on the treatment of difficult-to-treat infectious diseases. Antibiotic resistances of pathogens complicate standard medical approaches.
Optical technologies provide additional diagnostic information, high precision and personalization. This allows for fast diagnoses for time-sensitive infections.
Artificial Intelligence helps with fast and automated evaluation of complex photonic data. This allows for reliable diagnostic decisions.
A unique translation infrastructure for the development of medical solutions: LPI bridges the gap from research concept to the clinical practice and thus combines technology development and real life application.
How can photonic technologies be rapidly and successfully brought into clinical application? The LPI addressed this question in its program […]
For the latest edition of the LPI basic technology meeting on May 21, 2026, nearly 100 participants gathered at the […]
Forward-thinking priorities were established in the High-Tech Agenda Germany published by the BMFTR on May 21, 2026. The LPI is […]

Excellent science and globally active companies in the fields of optics and photonics, medical technology and analytics as well as a lively start-up scene make scientific and business location Jena an innovation driver in the field of optical health technologies.
The LPI builds on the competencies of the University Hospital and the Friedrich Schiller University as well as the Leibniz Institute of Photonic Technology (Leibniz-IPHT) and Natural Product Research and Infection Biology (Leibniz-HKI) located here. The four supporting institutions participate in established research associations, DFG special research areas, the „Balance of the MicroVerse“ cluster of excellence as well as federally funded projects such as the „InfectoGnostics“ research campus and the „Center for Sepsis and Infection Research“ (Center for Sepsis Control & Care, CSCC).
An initiative of the Leibniz Association in cooperation with